During the last session, Galectin Therapeutics Inc (NASDAQ:GALT)’s traded shares were 0.39 million, with the beta value of the company hitting 0.78. At the end
In the last trading session, 1.94 million Galectin Therapeutics Inc (NASDAQ:GALT) shares changed hands as the company’s beta touched 0.70. With the company’s per share
Galectin Therapeutics Inc (NASDAQ:GALT) has a beta value of 100.00% and has seen 468.62 shares traded in the last trading session. The company, currently valued
In the last trading session, 11.54 million shares of the Galectin Therapeutics Inc (NASDAQ:GALT) were traded, and its beta was 0.55. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne